hpv vaccine Search Results


l1 proteins of hpv 16 and 18  (VBI Vaccines)
90
VBI Vaccines l1 proteins of hpv 16 and 18
Prophylactic HPV vaccines that have been approved for marketing.
L1 Proteins Of Hpv 16 And 18, supplied by VBI Vaccines, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/l1+proteins+of+hpv+16+and+18/pmc11598756-36-6-14
Average 90 stars, based on 1 article reviews
l1 proteins of hpv 16 and 18 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
vlp-based multivalent recombinant hpv vaccine  (Sinocelltech Ltd)
90
Sinocelltech Ltd vlp-based multivalent recombinant hpv vaccine
Prophylactic HPV vaccines that have been approved for marketing.
Vlp Based Multivalent Recombinant Hpv Vaccine, supplied by Sinocelltech Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/vlp+based+multivalent+recombinant+hpv+vaccine/pm37635425-28-4-11
Average 90 stars, based on 1 article reviews
vlp-based multivalent recombinant hpv vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
hpv vaccine  (John Snow Inc)
90
John Snow Inc hpv vaccine
Prophylactic HPV vaccines that have been approved for marketing.
Hpv Vaccine, supplied by John Snow Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/hpv+vaccine/pmc09486230__bmjopen___2021___058450__draft_revisions-916-5-0
Average 90 stars, based on 1 article reviews
hpv vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
hpv vaccine  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare hpv vaccine
Prophylactic HPV vaccines that have been approved for marketing.
Hpv Vaccine, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/hpv+vaccine/pmc03394158-137-7-11
Average 90 stars, based on 1 article reviews
hpv vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
therapeutic human papilloma virus (hpv) vaccine  (Genticel Inc)
90
Genticel Inc therapeutic human papilloma virus (hpv) vaccine
Prophylactic HPV vaccines that have been approved for marketing.
Therapeutic Human Papilloma Virus (Hpv) Vaccine, supplied by Genticel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/therapeutic+human+papilloma+virus++hpv++vaccine/pm22002157-29-1-0
Average 90 stars, based on 1 article reviews
therapeutic human papilloma virus (hpv) vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
hpv vaccine  (Becton Dickinson)
90
Becton Dickinson hpv vaccine
Prophylactic HPV vaccines that have been approved for marketing.
Hpv Vaccine, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/hpv+vaccine/pm30638767-207-15-21
Average 90 stars, based on 1 article reviews
hpv vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
mrna hpv antigen cd40  (BioNTech)
90
BioNTech mrna hpv antigen cd40
Advantages and disadvantages of non-amplifying <t> mRNA </t> Vaccines and SAM Vaccines.
Mrna Hpv Antigen Cd40, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/hpv+anti+cd40+rna+vaccine/pmc08707022-17-2-18
Average 90 stars, based on 1 article reviews
mrna hpv antigen cd40 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
hpv vaccination program  (Rocha labs)
90
Rocha labs hpv vaccination program
Advantages and disadvantages of non-amplifying <t> mRNA </t> Vaccines and SAM Vaccines.
Hpv Vaccination Program, supplied by Rocha labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/hpv+vaccination+program/pm35849621-36-8-13
Average 90 stars, based on 1 article reviews
hpv vaccination program - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
hpv vaccine  (Merck KGaA)
90
Merck KGaA hpv vaccine
Advantages and disadvantages of non-amplifying <t> mRNA </t> Vaccines and SAM Vaccines.
Hpv Vaccine, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/hpv+vaccine/pm28893472-155-13-28
Average 90 stars, based on 1 article reviews
hpv vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
quadrivalent human papillomavirus recombinant vaccine gardasil  (Merck KGaA)
90
Merck KGaA quadrivalent human papillomavirus recombinant vaccine gardasil
Characteristics and distribution of high-risk <t> Human Papillomavirus </t> (HR-HPV) infection among women living in mid-western rural Nepal N = 998
Quadrivalent Human Papillomavirus Recombinant Vaccine Gardasil, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/hpv+vaccine+gardasil/pmc06053738-247-13-24
Average 90 stars, based on 1 article reviews
quadrivalent human papillomavirus recombinant vaccine gardasil - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
hpv g vaccine dose 2  (MATHESON)
90
MATHESON hpv g vaccine dose 2
Characteristics and distribution of high-risk <t> Human Papillomavirus </t> (HR-HPV) infection among women living in mid-western rural Nepal N = 998
Hpv G Vaccine Dose 2, supplied by MATHESON, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/hpv+vaccine/pmc05415660-79-7-0
Average 90 stars, based on 1 article reviews
hpv g vaccine dose 2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
hpv vaccine  (Geneus Health LLC)
90
Geneus Health LLC hpv vaccine
Characteristics and distribution of high-risk <t> Human Papillomavirus </t> (HR-HPV) infection among women living in mid-western rural Nepal N = 998
Hpv Vaccine, supplied by Geneus Health LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+vaccine/hpv+vaccine/pm36949438-299-31-9
Average 90 stars, based on 1 article reviews
hpv vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Prophylactic HPV vaccines that have been approved for marketing.

Journal: Vaccines

Article Title: Human Papillomavirus-Related Cancer Vaccine Strategies

doi: 10.3390/vaccines12111291

Figure Lengend Snippet: Prophylactic HPV vaccines that have been approved for marketing.

Article Snippet: , VB10.16 , Phase II , L1 proteins of HPV 16 and 18 , VBI Vaccines, Inc., Cambridge, MA, USA.

Techniques: Vaccines, Produced, Expressing, Adjuvant, Injection, Infection

Globally in-clinical-stage prophylactic and therapeutic HPV vaccines.

Journal: Vaccines

Article Title: Human Papillomavirus-Related Cancer Vaccine Strategies

doi: 10.3390/vaccines12111291

Figure Lengend Snippet: Globally in-clinical-stage prophylactic and therapeutic HPV vaccines.

Article Snippet: , VB10.16 , Phase II , L1 proteins of HPV 16 and 18 , VBI Vaccines, Inc., Cambridge, MA, USA.

Techniques: Vaccines, Clinical Proteomics

Advantages and disadvantages of non-amplifying mRNA Vaccines and SAM Vaccines.

Journal: Pharmaceutics

Article Title: mRNA, a Revolution in Biomedicine

doi: 10.3390/pharmaceutics13122090

Figure Lengend Snippet: Advantages and disadvantages of non-amplifying mRNA Vaccines and SAM Vaccines.

Article Snippet: HARE-40 , mRNA , HPV antigen CD40 , I.D , Naked RNA , HPV-driven squamous cell carcinoma , BioNTech , NCT03418480 , I/II , , Immunotherapy.

Techniques: Vaccines, Sequencing, Expressing, Modification, Virus, Adjuvant, Immunopeptidomics

Clinical trials for RNA-Based Protein Therapy (Protein replacement, cell reprogramming, immunotherapy) and gene editing.

Journal: Pharmaceutics

Article Title: mRNA, a Revolution in Biomedicine

doi: 10.3390/pharmaceutics13122090

Figure Lengend Snippet: Clinical trials for RNA-Based Protein Therapy (Protein replacement, cell reprogramming, immunotherapy) and gene editing.

Article Snippet: HARE-40 , mRNA , HPV antigen CD40 , I.D , Naked RNA , HPV-driven squamous cell carcinoma , BioNTech , NCT03418480 , I/II , , Immunotherapy.

Techniques: Clinical Proteomics, Injection, Virus, Infection, Expressing, CRISPR, Ex Vivo, Plasmid Preparation, Modification

mRNA vaccines and new candidates for COVID-19 [ <xref ref-type= 150 ]." width="100%" height="100%">

Journal: Pharmaceutics

Article Title: mRNA, a Revolution in Biomedicine

doi: 10.3390/pharmaceutics13122090

Figure Lengend Snippet: mRNA vaccines and new candidates for COVID-19 [ 150 ].

Article Snippet: HARE-40 , mRNA , HPV antigen CD40 , I.D , Naked RNA , HPV-driven squamous cell carcinoma , BioNTech , NCT03418480 , I/II , , Immunotherapy.

Techniques: Vaccines, Clinical Proteomics, Derivative Assay, Plasmid Preparation, Variant Assay

Characteristics and distribution of high-risk Human Papillomavirus (HR-HPV) infection among women living in mid-western rural Nepal N = 998

Journal: BMC Infectious Diseases

Article Title: Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study

doi: 10.1186/s12879-018-3175-9

Figure Lengend Snippet: Characteristics and distribution of high-risk Human Papillomavirus (HR-HPV) infection among women living in mid-western rural Nepal N = 998

Article Snippet: A pilot vaccination program was launched among 1096 school girls in Nepal giving quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil; Merk & Co.).

Techniques: Infection, Virus

Type-specific distribution of Human Papillomavirus (HPV) infection among women living in mid-western rural Nepal N = 998

Journal: BMC Infectious Diseases

Article Title: Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study

doi: 10.1186/s12879-018-3175-9

Figure Lengend Snippet: Type-specific distribution of Human Papillomavirus (HPV) infection among women living in mid-western rural Nepal N = 998

Article Snippet: A pilot vaccination program was launched among 1096 school girls in Nepal giving quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil; Merk & Co.).

Techniques: Infection

Human Papillomavirus (HPV) infection according to the age group of women living in mid-western rural Nepal

Journal: BMC Infectious Diseases

Article Title: Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study

doi: 10.1186/s12879-018-3175-9

Figure Lengend Snippet: Human Papillomavirus (HPV) infection according to the age group of women living in mid-western rural Nepal

Article Snippet: A pilot vaccination program was launched among 1096 school girls in Nepal giving quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil; Merk & Co.).

Techniques: Infection, Western Blot

Trends of Human Papillomavirus (HPV) infection according to the age group of women living in mid-western rural Nepal

Journal: BMC Infectious Diseases

Article Title: Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study

doi: 10.1186/s12879-018-3175-9

Figure Lengend Snippet: Trends of Human Papillomavirus (HPV) infection according to the age group of women living in mid-western rural Nepal

Article Snippet: A pilot vaccination program was launched among 1096 school girls in Nepal giving quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil; Merk & Co.).

Techniques: Infection, Western Blot

Univariate analyses of potential risk factors for high-risk Human Papillomavirus (HR-HPV) in women living in mid-western rural Nepal

Journal: BMC Infectious Diseases

Article Title: Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study

doi: 10.1186/s12879-018-3175-9

Figure Lengend Snippet: Univariate analyses of potential risk factors for high-risk Human Papillomavirus (HR-HPV) in women living in mid-western rural Nepal

Article Snippet: A pilot vaccination program was launched among 1096 school girls in Nepal giving quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil; Merk & Co.).

Techniques:

Prevalence of high-risk Human Papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology

Journal: BMC Infectious Diseases

Article Title: Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study

doi: 10.1186/s12879-018-3175-9

Figure Lengend Snippet: Prevalence of high-risk Human Papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology

Article Snippet: A pilot vaccination program was launched among 1096 school girls in Nepal giving quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil; Merk & Co.).

Techniques: Infection